Home
About
Pricing
Log In
Back
LKEAM

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

🇦🇺 ASX

👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

7
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Lake Resources N.L. - Option Expiring 15-Oct-2021 Deferred

📈 Performance

Price History

N/A

1M

All Time

Graph

Table

empty share chartempty share line

Performance graph isn't available yet for this share

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in LKEAM

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in LKEAM

N/A
LKEAM investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in LKEAM also invest in...

Lake Resources N.L.

LKE

Lake Resources NL, is a lithium exploration company, which focuses on exploring lithium basins and pegmatites in Argentina. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-08-29. The firm also has three additional early-stage projects in this region, including Olaroz, Cauchari and Pasode Jama. The flagship Kachi Project is located in Argentina’s Catamarca Province at the southern end of the Lithium Triangle. The project comprises 705 square kilometers (Km2) of leases and lease applications over a brine-bearing basin 20 kilometers (km) long, 15 km wide and 400-800 meter deep centered. The Cauchari Lithium Brine Project in Jujuy Province. The Paso de Jama Lithium Brine Project in Jujuy Province is comprised of over 59,000 hectares. The Olaroz Lithium Brine Project covers 45,000 hectares.

🙌 Performance (5Yr p.a)

1.67%

📊 Share price

$0.04 AUD

⛏️ MINING

Find Out More

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

🙌 Performance (5Yr p.a)

11.63%

📊 Share price

$15.75 AUD

🌏 GLOBAL

🤖 TECHNOLOGY

⛳️ DIVERSIFIED

📈 HIGH PRICE GROWTH

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.

🙌 Performance (5Yr p.a)

71.38%

📊 Share price

$0.27 AUD

🧬 BIOTECHNOLOGY

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

🙌 Performance (5Yr p.a)

13.61%

📊 Share price

$100.30 AUD

🌏 GLOBAL

🤖 TECHNOLOGY

🏭 INDUSTRIALS

🧱 MATERIALS

📈 HIGH PRICE GROWTH

Vulcan Energy Resources Ltd. operates as a lithium producer with net zero greenhouse gas emissions. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-05-30. The Company’s segments include Germany, Other European (France and Italy) and Australia. The Germany segment is engaged in the supply of geothermal energy, exploration relating to the Zero Carbon Lithium Project and engineering services. The Other European segment is engaged in exploration relating to battery materials and geothermal lithium. The Australia segment is engaged in administration and corporate support services. Its products include Geothermal energy, Sustainable Lithium, and In-house sorbent: VULSORB. The Company’s Lionheart Project is located in the Upper Rhine Valley Brine Field bordering Germany and France, is the lithium resource in Europe and a tier-one lithium project globally. Its subsidiaries include Vulcan Energie Ressourcen GmbH, Vulcan Energy Europe Pty Limited, and Vulcan Energy Engineering GmbH, among others.

🙌 Performance (5Yr p.a)

106.84%

📊 Share price

$3.71 AUD

⛏️ MINING

Want more shares? Try these...